KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends Paid - Common (2016 - 2025)

Eli Lilly (LLY) has disclosed Dividends Paid - Common for 17 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Dividends Paid - Common rose 15.21% year-over-year to $1.3 billion, compared with a TTM value of $5.4 billion through Dec 2025, up 15.04%, and an annual FY2025 reading of $5.4 billion, up 15.04% over the prior year.
  • Dividends Paid - Common was $1.3 billion for Q4 2025 at Eli Lilly, roughly flat from $1.3 billion in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.3 billion in Q2 2025 and bottomed at $768.3 million in Q2 2021.
  • Average Dividends Paid - Common over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
  • Peak annual rise in Dividends Paid - Common hit 15.42% in 2021, while the deepest fall reached 13.96% in 2021.
  • Year by year, Dividends Paid - Common stood at $773.3 million in 2021, then grew by 14.37% to $884.4 million in 2022, then grew by 15.08% to $1.0 billion in 2023, then grew by 14.75% to $1.2 billion in 2024, then grew by 15.21% to $1.3 billion in 2025.
  • Business Quant data shows Dividends Paid - Common for LLY at $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.